• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情在冲突地区:阿拉伯黎凡特的应对。

COVID-19 in conflict region: the arab levant response.

机构信息

Faculty of Medicine, University of Balamand, Koura, Lebanon.

Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

BMC Public Health. 2021 Aug 26;21(1):1590. doi: 10.1186/s12889-021-11580-4.

DOI:10.1186/s12889-021-11580-4
PMID:34445976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8390061/
Abstract

BACKGROUND

COVID-19 has hit the world in an unprecedented way causing serious repercussions on several aspects of our life. Multiple determinants have affected various nations' level of success in their responses towards the pandemic. The Arab Levant region in the Middle East, notoriously known for repeated wars and conflicts, has been affected, similarly to other regions, by this pandemic. The combination of war, conflict, and a pandemic brings too much of a burden for any nation to handle.

METHODS

A descriptive analysis of data obtained from the health departments of various Arab Levant Countries (ALC) was performed. ALC include Lebanon, Syria, Jordan, Iraq and Palestine. The data collected involves incidence, recovery rate, case fatality rate and number of tests performed per million population, Global Health Security index, government stringency index, and political stability index. The information obtained was compared and analyzed among the ALC and compared to global figures. An extensive electronic literature search to review all relevant articles and reports published from the region was conducted. The 2019 Global Health Security (GHS) index was obtained from the "GHS index" website which was made by John Hopkins University's center for health security, the Nuclear threat Initiative (NTI) and the Economist Intelligence Unit (EIU). Government stringency index and political stability index were obtained from the University of Oxford and the website of "The Global Economy", respectively. Other world governance indicators such as government effectiveness were obtained from the World Bank website.

RESULTS

In terms of incidence of COVID-19, Iraq has the highest with 9665 per one million population, Syria the lowest at 256 per million. Deaths per million population was highest in Iraq at 237, and the lowest in Syria at 12. As for number of tests per million population, Lebanon ranked first at 136,033 with Iraq fourth at 59,795. There is no data available for the tests administered in Syria and subsequently no value for tests per million population. In terms of recoveries from COVID-19 per million population, Iraq had the highest number at 7903 per million, and Syria the lowest at 68 per million. When compared as percent recovery per million, Palestine ranked first (84%) and Syria last (27%). The government response stringency index shows that Jordan had the highest index (100) early in the pandemic among the other countries. Palestine's index remained stable between 80 and 96. The other countries' indices ranged from 50 to 85, with Lebanon seeing a drop to 24 in mid-August. Even with improved stringency index, Iraq reported an increased number of deaths.

CONCLUSION

In countries devastated by war and conflict, a pandemic such as COVID-19 can easily spread. The Arab Levant countries represent a breeding ground for pandemics given their unstable political and economic climate that has undoubtedly affected their healthcare systems. In the era of COVID-19, looking at healthcare systems as well as political determinants is needed to assess a country's readiness towards the pandemic. The unrest in Lebanon, the uprising in Iraq, the restrictions placed on Syria, and the economic difficulties in Palestine are all examples of determinants affecting pandemic management. Jordan, on the contrary, is a good example of a stable state, able to implement proper measures. Political stability index should be used as a predictor for pandemic management capacity, and individual measures should be tailored towards countries depending on their index.

摘要

背景

COVID-19 以空前的方式席卷全球,对我们生活的多个方面产生了严重影响。多种决定因素影响了各国应对这一大流行病的成功程度。中东的阿拉伯黎凡特地区以反复发生的战争和冲突而闻名,与其他地区一样,也受到了这一大流行病的影响。战争、冲突和大流行病的结合给任何国家都带来了太大的负担。

方法

对来自各个阿拉伯黎凡特国家(ALC)卫生部门的数据进行了描述性分析。ALC 包括黎巴嫩、叙利亚、约旦、伊拉克和巴勒斯坦。收集的数据包括发病率、康复率、病死率和每百万人进行的检测数量、全球卫生安全指数、政府严格指数和政治稳定指数。对 ALC 之间的信息进行了比较和分析,并与全球数据进行了比较。对该地区发表的所有相关文章和报告进行了广泛的电子文献检索。2019 年全球卫生安全(GHS)指数来自约翰霍普金斯大学健康安全中心、核威胁倡议(NTI)和经济学人智库(EIU)的“GHS 指数”网站。政府严格指数和政治稳定指数分别来自牛津大学和“全球经济”网站。其他世界治理指标,如政府效能,来自世界银行网站。

结果

就 COVID-19 的发病率而言,伊拉克最高,每百万人中有 9665 人,叙利亚最低,每百万人中有 256 人。每百万人的死亡人数以伊拉克最高,为 237 人,叙利亚最低,为 12 人。至于每百万人进行的检测数量,黎巴嫩以 136033 次排名第一,伊拉克以 59795 次排名第四。叙利亚没有提供进行的检测数据,因此没有每百万人进行的检测数量值。就 COVID-19 的每百万人康复人数而言,伊拉克以每百万人 7903 人位居榜首,叙利亚以每百万人 68 人位居垫底。按每百万人的康复百分比计算,巴勒斯坦排名第一(84%),叙利亚排名最后(27%)。政府应对严格指数显示,在疫情早期,约旦是其他国家中政府应对严格指数最高的国家(100)。巴勒斯坦的指数在 80 到 96 之间保持稳定。其他国家的指数在 50 到 85 之间,黎巴嫩在 8 月中旬降至 24。即使政府应对指数有所提高,伊拉克的死亡人数也有所增加。

结论

在饱受战争和冲突蹂躏的国家,COVID-19 等大流行病很容易传播。阿拉伯黎凡特国家政局动荡,经济气候不稳定,这无疑影响了他们的医疗体系,是大流行病的滋生地。在 COVID-19 时代,需要审视医疗体系以及政治决定因素,以评估一个国家对大流行病的准备情况。黎巴嫩的动荡、伊拉克的起义、叙利亚的限制以及巴勒斯坦的经济困难都是影响大流行病管理的决定因素的例子。相比之下,约旦是一个稳定的国家,能够实施适当的措施,是一个很好的例子。政治稳定指数应作为大流行病管理能力的预测指标,应根据指数为各国量身定制个别措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/1dc788d4d843/12889_2021_11580_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/df8c0ac320c9/12889_2021_11580_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/410ff6cc1187/12889_2021_11580_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/67de1645d97c/12889_2021_11580_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/4c00f0e61ba0/12889_2021_11580_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/0f32efb7debb/12889_2021_11580_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/caeb62f61254/12889_2021_11580_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/937ecd01e9c5/12889_2021_11580_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/a70d4c824cdc/12889_2021_11580_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/6d92b9aebb10/12889_2021_11580_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/2297a01a8b3d/12889_2021_11580_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/71913fc33eaf/12889_2021_11580_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/4adf48ab851c/12889_2021_11580_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/1dc788d4d843/12889_2021_11580_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/df8c0ac320c9/12889_2021_11580_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/410ff6cc1187/12889_2021_11580_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/67de1645d97c/12889_2021_11580_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/4c00f0e61ba0/12889_2021_11580_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/0f32efb7debb/12889_2021_11580_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/caeb62f61254/12889_2021_11580_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/937ecd01e9c5/12889_2021_11580_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/a70d4c824cdc/12889_2021_11580_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/6d92b9aebb10/12889_2021_11580_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/2297a01a8b3d/12889_2021_11580_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/71913fc33eaf/12889_2021_11580_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/4adf48ab851c/12889_2021_11580_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f25/8390220/1dc788d4d843/12889_2021_11580_Fig13_HTML.jpg

相似文献

1
COVID-19 in conflict region: the arab levant response.新冠疫情在冲突地区:阿拉伯黎凡特的应对。
BMC Public Health. 2021 Aug 26;21(1):1590. doi: 10.1186/s12889-021-11580-4.
2
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.中东和北非地区的 SARS-CoV-2 监测:纵向趋势分析。
J Med Internet Res. 2021 Jan 15;23(1):e25830. doi: 10.2196/25830.
3
Diverging levels of COVID-19 governmental response satisfaction across middle eastern Arab countries: a multinational study.不同中东阿拉伯国家对 COVID-19 政府应对措施满意度的差异:一项多国研究。
BMC Public Health. 2022 May 5;22(1):893. doi: 10.1186/s12889-022-13292-9.
4
The Impact of Armed Conflict on the Epidemiological Situation of COVID-19 in Libya, Syria and Yemen.武装冲突对利比亚、叙利亚和也门 COVID-19 流行病学情况的影响。
Front Public Health. 2021 Jun 11;9:667364. doi: 10.3389/fpubh.2021.667364. eCollection 2021.
5
Socioeconomic differences in smoking in Jordan, Lebanon, Syria, and Palestine: A cross-sectional analysis of national surveys.约旦、黎巴嫩、叙利亚和巴勒斯坦吸烟情况的社会经济差异:全国调查的横断面分析
PLoS One. 2018 Jan 30;13(1):e0189829. doi: 10.1371/journal.pone.0189829. eCollection 2018.
6
One-year Review of COVID-19 in the Arab World.阿拉伯世界新冠疫情一周年回顾
Qatar Med J. 2021 Nov 27;2021(3):66. doi: 10.5339/qmj.2021.66. eCollection 2021.
7
COVID-19 Statistics in the Arab World by the End of October 2022: A Cross-Sectional Study.2022年10月底阿拉伯世界的新冠疫情统计:一项横断面研究。
Cureus. 2022 Dec 18;14(12):e32670. doi: 10.7759/cureus.32670. eCollection 2022 Dec.
8
Infant and child mortality rates among Palestinian refugee populations.巴勒斯坦难民群体中的婴幼儿死亡率
Lancet. 2000 Jul 22;356(9226):312. doi: 10.1016/S0140-6736(00)02511-3.
9
Resilience capacities of health systems: Accommodating the needs of Palestinian refugees from Syria.卫生系统的弹性能力:满足来自叙利亚的巴勒斯坦难民的需求。
Soc Sci Med. 2019 Jan;220:22-30. doi: 10.1016/j.socscimed.2018.10.018. Epub 2018 Oct 21.
10
[Family planning and reproductive behavior in Islamic countries in the Mediterranean area].[地中海地区伊斯兰国家的计划生育与生殖行为]
Genus. 1990 Jan-Jun;46(1-2):109-30.

引用本文的文献

1
Psychological antecedents of vaccine inequity: keys to improve the rates of vaccination.疫苗不平等的心理成因:提高疫苗接种率的关键
J Egypt Public Health Assoc. 2024 Dec 4;99(1):31. doi: 10.1186/s42506-024-00175-7.
2
Validity and reliability of chemical-based disinfectant use questionnaire in a sample of the Lebanese public community.基于化学消毒剂使用的调查问卷在黎巴嫩公众社区样本中的有效性和可靠性。
BMJ Open. 2024 Oct 18;14(10):e082268. doi: 10.1136/bmjopen-2023-082268.
3
The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region.

本文引用的文献

1
A sharp increase in the number of COVID-19 cases and case fatality rates after lifting the lockdown in Kurdistan region of Iraq.伊拉克库尔德斯坦地区解除封锁后,新冠病毒疾病病例数和病死率急剧上升。
Ann Med Surg (Lond). 2020 Jul 24;57:140-142. doi: 10.1016/j.amsu.2020.07.030. eCollection 2020 Sep.
2
COVID-19 Response in Lebanon: Current Experience and Challenges in a Low-Resource Setting.黎巴嫩的新冠疫情应对:资源匮乏环境下的当前经验与挑战
JAMA. 2020 Aug 11;324(6):548-549. doi: 10.1001/jama.2020.12695.
3
COVID-19 Pandemic: An Insult Over Injury for Lebanon.
《COVID-19 疫苗犹豫现象及其对大流行控制努力的负面影响:中东和北非(MENA)地区出现的共同主题》。
Adv Exp Med Biol. 2024;1457:299-322. doi: 10.1007/978-3-031-61939-7_17.
4
Prepared for the polycrisis? The need for complexity science and systems thinking to address global and national evidence gaps.为多元危机做好准备?需要复杂性科学和系统思维来解决全球和国家的证据差距。
BMJ Glob Health. 2024 Sep 11;9(9):e014887. doi: 10.1136/bmjgh-2023-014887.
5
Parents' Knowledge and Attitudes Regarding COVID-19: Evidence From a Tertiary Healthcare Center in Irbid, Jordan.父母对新冠病毒的认知与态度:来自约旦伊尔比德一家三级医疗中心的证据
Cureus. 2024 Jul 20;16(7):e64967. doi: 10.7759/cureus.64967. eCollection 2024 Jul.
6
Strengthening laboratories in response to outbreaks in humanitarian emergencies and conflict settings: Results, challenges and lessons from expanding PCR diagnostic capacities for COVID-19 testing in Yemen.应对人道主义紧急情况和冲突环境中的疫情爆发:在也门扩大 COVID-19 检测 PCR 诊断能力的结果、挑战和经验教训。
PLoS One. 2024 Feb 23;19(2):e0298603. doi: 10.1371/journal.pone.0298603. eCollection 2024.
7
'What we lacked was the courage to take decisions that differed from the rest of the world': expert perspectives on the role of evidence in COVID-19 policymaking in Iraq.“我们所缺乏的是做出有别于世界其他地区的决策的勇气”:伊拉克新冠疫情决策中证据作用的专家观点。
BMJ Glob Health. 2023 Nov 30;8(11):e012926. doi: 10.1136/bmjgh-2023-012926.
8
Lessons learnt from the first wave of COVID-19 in Damascus, Syria: a multicentre retrospective cohort study.叙利亚大马士革首例 COVID-19 浪潮的经验教训:一项多中心回顾性队列研究。
BMJ Open. 2023 Jul 20;13(7):e065280. doi: 10.1136/bmjopen-2022-065280.
9
The COVID-19 experience in Africa and the Middle East.非洲和中东的 COVID-19 经历。
Ann Med. 2023 Dec;55(1):2222641. doi: 10.1080/07853890.2023.2222641.
10
Exploring the worldwide impact of COVID-19 on conflict risk under climate change.探索新冠疫情对气候变化下冲突风险的全球影响。
Heliyon. 2023 Jun;9(6):e17182. doi: 10.1016/j.heliyon.2023.e17182. Epub 2023 Jun 10.
新冠疫情:黎巴嫩雪上加霜。
J Community Health. 2021 Jun;46(3):487-493. doi: 10.1007/s10900-020-00884-y.
4
EU guidance impedes humanitarian action to prevent COVID-19 in Syria.欧盟的指导方针阻碍了在叙利亚预防新冠疫情的人道主义行动。
Lancet Glob Health. 2020 Sep;8(9):e1112-e1113. doi: 10.1016/S2214-109X(20)30289-8. Epub 2020 Jul 2.
5
Challenges to testing COVID-19 in conflict zones: Yemen as an example.在冲突地区进行新冠病毒检测面临的挑战:以也门为例。
J Glob Health. 2020 Jun;10(1):010375. doi: 10.7189/jogh.10.010375.
6
Coronavirus Disease 2019 (COVID-19): Potential implications for weak health systems and conflict zones in the Middle East and North Africa region.2019 年冠状病毒病(COVID-19):对中东和北非地区薄弱卫生系统和冲突地区的潜在影响。
Int J Health Plann Manage. 2020 Sep;35(5):1240-1245. doi: 10.1002/hpm.2982. Epub 2020 Jun 19.
7
Health system's response to the COVID-19 pandemic in conflict settings: Policy reflections from Palestine.冲突环境下卫生系统对 COVID-19 大流行的应对:来自巴勒斯坦的政策反思。
Glob Public Health. 2020 Aug;15(8):1244-1256. doi: 10.1080/17441692.2020.1781914. Epub 2020 Jun 17.
8
COVID-19 Crisis in Jordan: Response, Scenarios, Strategies, and Recommendations.约旦的 COVID-19 危机:应对措施、情景、策略和建议。
JMIR Public Health Surveill. 2020 Jul 7;6(3):e19332. doi: 10.2196/19332.
9
Incidence of the COVID-19 in Iraq - Implications for travellers.伊拉克新冠肺炎的发病率——对旅行者的影响。
Travel Med Infect Dis. 2020 Nov-Dec;38:101739. doi: 10.1016/j.tmaid.2020.101739. Epub 2020 May 13.
10
Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria.2019 年冠状病毒病与受长期冲突影响的卫生系统:以叙利亚为例。
Int J Infect Dis. 2020 Jul;96:192-195. doi: 10.1016/j.ijid.2020.05.003. Epub 2020 May 8.